About Eslicarbazepine
Class: | Antiepileptic drug (AED), Sodium channel blocker
Use: | Treatment of partial-onset seizures in adults and children aged 4 years and older with epilepsy
Adult dose: | Initial dose of 400 mg once daily; may be increased to a maximum of 800 mg once daily based on clinical response and tolerability
Pediatric dose: | For children aged 4 to 17 years, initial dose of 10 mg/kg once daily (up to 400 mg); may be increased to a maximum of 20 mg/kg once daily (up to 800 mg)
Side effects: |
Drug Class
Antiepileptic drug (AED), Sodium channel blocker
Uses & Indications
Treatment of partial-onset seizures in adults and children aged 4 years and older with epilepsy
Storage Requirements
Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from moisture and light
Manufacturer & Packaging
Manufacturer: BIAL- PORTELA & C, S.A, PORTUGAL
Package Size
30s
Price & Supplier
Price in UAE: AED 688.00
Dosage Information
Adult Dose
Initial dose of 400 mg once daily; may be increased to a maximum of 800 mg once daily based on clinical response and tolerability
Pediatric Dose
For children aged 4 to 17 years, initial dose of 10 mg/kg once daily (up to 400 mg); may be increased to a maximum of 20 mg/kg once daily (up to 800 mg)
Side Effects
Dizziness, drowsiness, fatigue, nausea, vomiting, headache, double vision, and skin rash
Contraindications & Precautions
Hypersensitivity to eslicarbazepine acetate or any of its components; severe hepatic impairment
Important Warnings
Risk of serious skin reactions (e.g., Stevens-Johnson syndrome), hyponatremia, and suicidal thoughts or behavior; monitor for signs of mood changes and skin reactions during treatment
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.